Patents by Inventor Martin GAMER

Martin GAMER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Marker sequences for diagnosing and stratifying systemic sclerosis patients
    Patent number: 11609237
    Abstract: The present invention relates to methods for identifying markers for systemic sclerosis (also scleroderma; SSc) and to the markers identified with the aid of this method, which can differentiate between SSc and other autoimmune diseases on the one hand and between different SSc subgroups on the other hand. The invention also relates to panels, diagnostic devices and test kits which comprise these markers, and to the use and application thereof, for example for the diagnosis, prognosis and therapy control of SSc. The invention also relates to methods for screening and for validating active substances for use in SSc.
    Type: Grant
    Filed: December 4, 2019
    Date of Patent: March 21, 2023
    Assignee: ONCIMMUNE GERMANY GMBH
    Inventors: Petra Budde, Peter Schulz-Knappe, Angelika Luking, Martin Gamer
  • MARKER SEQUENCES FOR DIAGNOSING AND STRATIFYING SYSTEMIC SCLEROSIS PATIENTS
    Publication number: 20210003590
    Abstract: The present invention relates to methods for identifying markers for systemic sclerosis (also scleroderma; SSc) and to the markers identified with the aid of this method, which can differentiate between SSc and other autoimmune diseases on the one hand and between different SSc subgroups on the other hand. The invention also relates to panels, diagnostic devices and test kits which comprise these markers, and to the use and application thereof, for example for the diagnosis, prognosis and therapy control of SSc. The invention also relates to methods for screening and for validating active substances for use in SSc.
    Type: Application
    Filed: December 4, 2019
    Publication date: January 7, 2021
    Applicant: Oncimmune Germany GmbH
    Inventors: Petra BUDDE, Peter SCHULZ-KNAPPE, Angelika LUKING, Martin GAMER
  • Marker sequences for diagnosing and stratifying systemic sclerosis patients
    Patent number: 10571477
    Abstract: The present invention relates to methods for identifying markers for systemic sclerosis (also scleroderma; SSc) and to the markers identified with the aid of this method, which can differentiate between SSc and other autoimmune diseases on the one hand and between different SSc subgroups on the other hand. The invention also relates to panels, diagnostic devices and test kits which comprise these markers, and to the use and application thereof, for example for the diagnosis, prognosis and therapy control of SSc. The invention also relates to methods for screening and for validating active substances for use in SSc.
    Type: Grant
    Filed: July 4, 2015
    Date of Patent: February 25, 2020
    Assignee: Protagen GmbH
    Inventors: Petra Budde, Peter Schulz-Knappe, Angelika Lüking, Martin Gamer
  • MARKER SEQUENCES FOR DIAGNOSING AND STRATIFYING SYSTEMIC SCLEROSIS PATIENTS
    Publication number: 20170199202
    Abstract: The present invention relates to methods for identifying markers for systemic sclerosis (also scleroderma; SSc) and to the markers identified with the aid of this method, which can differentiate between SSc and other autoimmune diseases on the one hand and between different SSc subgroups on the other hand. The invention also relates to panels, diagnostic devices and test kits which comprise these markers, and to the use and application thereof, for example for the diagnosis, prognosis and therapy control of SSc. The invention also relates to methods for screening and for validating active substances for use in SSc.
    Type: Application
    Filed: July 4, 2015
    Publication date: July 13, 2017
    Inventors: Petra BUDDE, Peter SCHULZ-KNAPPE, Angelika LÜKING, Martin GAMER
  • MARKER SEQUENCES FOR NEUROMYELITIS OPTICA (NMO) AND USE THEREOF
    Publication number: 20150323529
    Abstract: The present invention relates to new markers for Neuromyelitis Optica (NMO), a method for identifying markers for NMO, the use of the markers identified by the method, diagnostic devices, panels of markers, assays, protein arrays comprising markers for NMO and a method for detecting NMO.
    Type: Application
    Filed: November 27, 2013
    Publication date: November 12, 2015
    Inventors: Heike GÖHLER, Marquart KLAUS, Andrew CHAN, Peter SCHULZ-KNAPPE, Carmen THEEK, Anna TELAAR, Martin GAMER
  • MARKER SEQUENCES FOR RHEUMATOID ARTHRITIS
    Publication number: 20150293120
    Abstract: The present invention relates to a novel method for identifying marker sequences for rheumatoid arthritis, the novel marker sequences discovered with the aid of the method, and the diagnostic use thereof. The invention also relates to diagnostic devices containing such marker sequences for rheumatoid arthritis, in particular a protein biochip or beads (pellets), and use thereof.
    Type: Application
    Filed: March 27, 2013
    Publication date: October 15, 2015
    Inventors: Angelika LÜKING, Peter SCHULZ-KNAPPE, Heike GÖHLER, Martin GAMER, Carmen THEEK, Daniel CHAMRAD, Anna TELAAR, Matthias VON DARL, Matthias SCHNEIDER, Jessica SCHWERMANN